BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32128744)

  • 1. [Clinical practice guidelines for polycystic kidney diseases].
    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Xu D; Mei C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):277-283. PubMed ID: 32128744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease.
    Liebau MC; Serra AL
    Pediatr Nephrol; 2013 Sep; 28(9):1771-83. PubMed ID: 23239392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 2002; 113():211-24; discussion 224-6. PubMed ID: 12053711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and Severe Polycystic Kidney Disease and Related Ciliopathies: An Emerging Field of Interest.
    Bergmann C
    Nephron; 2019; 141(1):50-60. PubMed ID: 30359986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polycystic kidney diseases: molecular genetics and counselling].
    Lespinasse J; Fourcade J; Schir F
    Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the molecular diagnosis of polycystic kidney disease.
    Bergmann C
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1037-1054. PubMed ID: 28952822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal polycystic kidney disease.
    Verghese P; Miyashita Y
    Clin Perinatol; 2014 Sep; 41(3):543-60. PubMed ID: 25155726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models for human polycystic kidney disease.
    Nagao S; Kugita M; Yoshihara D; Yamaguchi T
    Exp Anim; 2012; 61(5):477-88. PubMed ID: 23095811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.
    Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP
    J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for early treatment of polycystic kidney disease.
    Grantham JJ
    Pediatr Nephrol; 2015 Jul; 30(7):1053-62. PubMed ID: 25022529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polycystic kidney disease--autopsy review from the period 1987-2007].
    Radojević-Skodrić S; Bogdanović L; Jovanović M; Baralić I; Savin M; Basta-Jovanović G
    Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():294-7. PubMed ID: 20804098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney: polycystic kidney disease.
    Paul BM; Vanden Heuvel GB
    Wiley Interdiscip Rev Dev Biol; 2014; 3(6):465-87. PubMed ID: 25186187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Dysfunction in Polycystic Kidney Disease: A Mini-Review.
    Dennis MR; Pires PW; Banek CT
    J Vasc Res; 2023; 60(3):125-136. PubMed ID: 37536302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic kidney disease: new understanding in the pathogenesis.
    Wilson PD
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic kidney disease in Sprague-Dawley rats.
    Shoieb A; Shirai N
    Exp Toxicol Pathol; 2015; 67(5-6):361-4. PubMed ID: 25753522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease.
    Seeman T; Fořtová M; Sopko B; Průša R; Pohl M; John U
    Ann Clin Biochem; 2019 Jan; 56(1):90-94. PubMed ID: 29874928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal recessive and dominant polycystic kidney diseases.
    Sessa A; Righetti M; Battini G
    Minerva Urol Nefrol; 2004 Dec; 56(4):329-38. PubMed ID: 15785425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising the management of polycystic kidney disease.
    Keenan D; Maxwell AP
    Practitioner; 2016 Feb; 260(1790):13-6, 2. PubMed ID: 27032221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.
    Alcalay NI; Sharma M; Vassmer D; Chapman B; Paul B; Zhou J; Brantley JG; Wallace DP; Maser RL; Vanden Heuvel GB
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1725-34. PubMed ID: 18829740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.